The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma

Gut

Volumn 57, Issue 11, 2008, Pages 1504-1508

  Canedo, P ^a,b   Corso, G ^c   Pereira, F ^a   Lunet, N ^b   Suriano, G ^a   Figueiredo, C ^a,b   Pedrazzani, C ^c   Moreira, H ^b   Barros, H ^b   Carneiro, F ^a,b   Seruca, R ^a,b   Roviello, F ^c   Machado, J C ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR 1; GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHRONIC GASTRITIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CARCINOMA;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GASTRITIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERFERON; RISK FACTORS; STOMACH NEOPLASMS;

EID: 54349104757     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.143578     Document Type: Article

References (28)

1. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
3. Correa P. A Human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
4. Sipponen P. Gastric cancer - a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol 1994;201:24-7.
5. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
6. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer [correction appears in Nature 2001;412:99]. Nature 2000;404:398-402.
7. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-9.
8. Figueiredo C, Machado JC. Pharoah P, et al. Helicobacter pylori and interleukin-1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
9. El Omar EM, Rabkin CS. Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.
10. Machado JC, Figueiredo C, Canedo P, et al. A pro-inflammatory genetic profile increases the risk of chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71.
11. Thye T, Burchard GD, Nilius M, et al. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet 2003;72:448-53.
12. Smythies LE, Waites KB, Lindsey JR, et al. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL4, but not IFN-gamma, gene-deficient mice. J Immunol 2000;165:1022-9.
13. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 2004;14:437-41.
14. Boom R, Sol CJA, Salimans MMM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
15. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995;86:248-9.
16. Schneider S, Roessli D, Excoffier L. Arlequin: A software for population genetics data analysis. Ver 2.000. Genetics and Biometry Lab. Dept. of Anthropology, University of Geneva, 2000.
17. Rosenzweig SD, Schaffer AA, Ding L, et al. Interferon-gamma receptor 1 promoter polymorphisms: population distribution and functional implications. Clin Immunol 2004;112:113-9.
18. Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol Suppl 1994;201:7-10.
19. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998;54:139-50.
20. Pociot F, Molvig J, Wogensen L, et al. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
21. Danis VA, Millington M, Hyland VJ, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Rα) gene polymorphism. Clin Exp Immunol 1995;99:303-10.
22. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195- 9.
23. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol 1998;47:195-8.
24. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-803.
25. Arend WP, Malyak M, Guthridge CJ, et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998;16:27-55.
26. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998;30:469-73.
27. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999;111:290-8.
28. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001;48:743-7.